Table 3.
Multidrug resistant profile of ESBL-EC isolates.
| Resistance profile | No. of isolates with resistance profile [N (%)] | Resistance category |
|---|---|---|
| AMC, AMX | 150 (58%) | Drug resistant |
| CAZ, NX | 167 (65%) | Drug resistant |
| AMC, NX, AMX | 140 (54%) | Drug resistant |
| AMC, CAZ, NX, AMX | 121 (47%) | Multidrug resistant |
| AMC, CAZ, TM, NX, AMX | 101 (39%) | Multidrug resistant |
| AMC, CAZ, TM, GM, NX, AMX | 58 (23%) | Multidrug resistant |
| AMC, CAZ, TM, GM, SXT, NX, AMX | 48 (19%) | Multidrug resistant |
| AMC, FOX, CAZ, TM, GM, SXT, NX, AMX | 19 (7%) | Multidrug resistant |
| AMC, FOX, CAZ, TM, GM, AN, SXT, NX, AMX | 3 (1%) | Multidrug resistant |
AMX, amoxicillin; AMC, amoxicillin/clavulanic acid; FOX, cefoxitin; NX, norfloxacin; CAZ, ceftazidime; GM, gentamicin; TM, tobramycin; AN, amikacin; SXT, trimethoprim/sulfamethoxazole.